Invesaro

Stocks Health care RENXF

OTC · Health care

Renalytix plc (RENXF)

Renalytix plc brought in $2.4M of revenue over the twelve months to September 30, 2024, down 18.7% from a year earlier. It posted a net loss of $28M. At September 30, 2024 it held $909K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 19, 2024.

Watch RENXF in 60 seconds
Price
$0.09
+32.88% on the day · September 25, 2026
52-week range $0.02 to $0.18
Market cap
$29.1M
Revenue (last 12 months)
$2.4M
-18.7% year on year
Net margin
-1,191.8%

What Renalytix plc does

Renalytix plc is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on OTC under the ticker RENXF.

Revenue and profit by year

Revenue
FY20: $0 $0 FY20FY21: $1.5M $1.5M FY21FY22: $3M $3M FY22FY23: $3.4M $3.4M FY23FY24: $2.3M $2.3M FY24
Net income
FY20: -$42.3M -$42.3M FY20FY20: -$9.8M -$9.8M FY20FY21: -$35.3M -$35.3M FY21FY22: -$45.3M -$45.3M FY22FY23: -$45.6M -$45.6M FY23FY24: -$33.5M -$33.5M FY24

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2024$2.3M-$29.6M-$33.5M-$0.31n/a
2023$3.4M-$42.2M-$45.6M-$0.55-$34.1M
2022$3M-$53.2M-$45.3M-$0.67-$46.5M
2021$1.5M-$31.9M-$35.3M-$0.49-$29.2M
2020$0-$10.3M-$9.8M-$0.17-$10.3M
2020n/a-$42.3M-$42.3M-$0.99-$6.5M

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Renalytix plc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. February 23, 2026
    Activist stake changed SCHEDULE 13D/A
  2. December 3, 2025
    Form F-6 POS filing F-6 POS
  3. September 4, 2025
    Form F-6 POS filing F-6 POS
  4. July 30, 2025
    Securities offering prospectus 424B3
  5. July 30, 2025
    Deregistration 15-12G
  6. July 29, 2025
    Form POS AM filing POS AM
  7. July 29, 2025
    Form POS AM filing POS AM
  8. July 29, 2025
    Form POS AM filing POS AM
  9. July 29, 2025
    Form POS AM filing POS AM
  10. July 29, 2025
    Form POS AM filing POS AM

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 5, 2024. Insider transactions on SEC

All filings on SEC EDGAR

Questions about RENXF

What does Renalytix plc do?

Renalytix plc is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on OTC under the ticker RENXF.

Is Renalytix plc profitable?

No. Over the twelve months to September 30, 2024 it reported a net loss of $28M on revenue of $2.4M.

How much revenue does Renalytix plc make?

Over the twelve months to September 30, 2024 Renalytix plc reported revenue of $2.4M. That is 18.7% less than a year earlier.

When did Renalytix plc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 19, 2024. It covers the period to September 30, 2024. Its newest filing of any kind is the activist stake changed from February 23, 2026.

Similar companies

LH
Labcorp Holdings Inc.
DGX
Quest Diagnostics Inc
FTRE
Fortrea Holdings Inc.
NTRA
Natera, Inc.
RDNT
RadNet, Inc.
GH
Guardant Health, Inc.

Compare RENXF with

Compare RENXF with any company

Follow RENXF

Get an email when Renalytix plc files with the SEC: results, executive changes, material agreements and annual reports.

Follow RENXF: get an email when it files

Where the numbers come from

Financial figures are the values Renalytix plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.